The Food and Drug Administration is expected soon to approve the first in a new class of drugs that can cure the leading cause of liver failure and liver cancer. The disease is hepatitis C, and more than 3 million Americans have it but most of them don't know it.
FDA set to approve hepatitis drug
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.